The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbial systems are a black box. We created Microbial INtelligence Explorer to “MINE” their secrets• Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination•

Category: Infectious Disease & AMR

FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms
Editor's Choice

FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Events Likely Due to Transmission of Pathogenic Organisms

MAR 13, 2020
Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis
Clinical & Manufacturing

Da Volterra announces positive Phase 2 results for DAV132, the first product protecting against the clinical consequences of intestinal microbiota dysbiosis

FEB 17, 2020
Finch Therapeutics Completes Enrollment in Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection
Clinical & Manufacturing

Finch Therapeutics Completes Enrollment in Trial of CP101, an Investigational Oral Full-Spectrum Microbiota® Therapy for the Prevention of Recurrent C. difficile Infection

JAN 8, 2020
Beware probiotics in ICU patients
Biotics and Supplements

Beware probiotics in ICU patients

NOV 20, 2019
Unknown Virus Discovered in Human Body
Infectious Disease & AMR

Unknown Virus Discovered in Human Body

NOV 13, 2019
Clostridium difficile infections may have a friend in fungi
Infectious Disease & AMR

Clostridium difficile infections may have a friend in fungi

AUG 29, 2019
Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
Finance

Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections

JUL 18, 2019
DuPont to Provide Probiotics for International Pediatric Sepsis Research
Biotics and Supplements

DuPont to Provide Probiotics for International Pediatric Sepsis Research

APR 26, 2019
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
Finance

Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics

APR 1, 2019
Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI
Clinical & Manufacturing

Acurx Announces First-In-Man Clinical Trial Data of ACX-362E for CDI

FEB 28, 2019
Bioharmony Therapeutics and Boehringer Ingelheim to Advance Bacteriophage Lysin Therapeutics
Finance

Bioharmony Therapeutics and Boehringer Ingelheim to Advance Bacteriophage Lysin Therapeutics

JAN 16, 2019